Evidence map›Paper›PMID 34357026›Full record

ArticleLife (Basel, Switzerland)2021

Genetic Investigation of Inverse Psoriasis.

Anikó Göblös, Emese Varga, Katalin Farkas, Kristóf Árvai, Lajos Kemény

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Anikó GöblösMTA-SZTE Dermatological Research Group, Eötvös Loránd Research Network, 6720 Szeged, Hungary.
Emese VargaDepartment of Dermatology and Allergology, University of Szeged, 6720 Szeged, Hungary.
Katalin FarkasDepartment of Medical Genetics, University of Szeged, 6720 Szeged, Hungary.
Kristóf ÁrvaiPentaCore Laboratory, 1094 Budapest, Hungary.
Lajos KeményMTA-SZTE Dermatological Research Group, Eötvös Loránd Research Network, 6720 Szeged, Hungary.
University of Szeged · HUHungarian Research Network

Funding

EU's Horizon 2020 research and innovation program 739593GINOP GINOP-2.3.2-15-2016-00015
6 · The paper itself

Abstract

Inverse psoriasis is considered to be a rare variant of plaque-type psoriasis and is associated with significantly impaired quality of life. Clinical manifestations and treatment options are somewhat different for each subtype. Identifying genetic variants that contribute to the susceptibility of different types of psoriasis might improve understanding of the etiology of the disease. Since we have no current knowledge about the genetic background of inverse psoriasis, whole exome sequencing was used to comprehensively assess genetic variations in five patients with exclusively inverse lesions. We detected six potentially pathogenic rare (MAF < 0.01) sequence variants that occurred in all investigated patients. The corresponding mutated genes were FN1, FBLN1, MYH7B, MST1R, RHOD, and SCN10A. Several mutations identified in this study are known to cause disease, but roles in psoriasis or other papulosquamous diseases have not previously been reported. Interestingly, potentially causative variants of established psoriasis-susceptibility genes were not identified. These outcomes are in agreement with our hypothesis that the inverse subtype is a different entity from plaque-type psoriasis.

Indexed as

genetic backgroundinverse psoriasispathogenic gene variantsWESwhole exome sequencing

Identifiers

PMID34357026
PMCPMC8306123
OpenAlexW3180905463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.